NovoCure's market cap is currently $1.64B. The company's EPS TTM is $-0.36; its P/E ratio is ―; NovoCure is scheduled to report earnings on July 24, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
